Product Name:(S)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one CAS NO:189028-95-3
Chemical & Physical Properties:
Appearance : White to Off-White powder
Boiling Point:572.73℃ at 760 mmHg
(S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one is used to Ezetimibe Intermediate.
Ezetimibe's current clinical drugs for the treatment of hyperlipidemia mainly include cholesterol synthesis inhibitors, phenoxy acids and bile acid sequestrants. Ezetimibe acts on the brush border of small intestinal cells to selectively inhibit the absorption of cholesterol in the biliary tract and food without affecting the absorption of fat-soluble vitamins, triglycerides and bile acid.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.